Cellumed Co.,Ltd. (KOSDAQ:049180)

Cellumed Statistics

Total Valuation

Cellumed has a market cap or net worth of KRW 81.93 billion. The enterprise value is 89.54 billion.

Market Cap	81.93B
Enterprise Value	89.54B

Important Dates

The next estimated earnings date is Friday, March 20, 2026.

Earnings Date	Mar 20, 2026
Ex-Dividend Date	n/a

Share Statistics

Cellumed has 54.95 million shares outstanding. The number of shares has increased by 13.80% in one year.

Current Share Class	54.95M
Shares Outstanding	54.95M
Shares Change (YoY)	+13.80%
Shares Change (QoQ)	-0.03%
Owned by Insiders (%)	0.55%
Owned by Institutions (%)	2.29%
Float	42.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.55
PB Ratio	4.96
P/TBV Ratio	5.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-4.20
EV / Sales	0.60
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-19.21

Financial Position

The company has a current ratio of 1.05, with a Debt / Equity ratio of 0.73.

Current Ratio	1.05
Quick Ratio	0.39
Debt / Equity	0.73
Debt / EBITDA	n/a
Debt / FCF	-2.60
Interest Coverage	-10.37

Financial Efficiency

Return on equity (ROE) is -86.73% and return on invested capital (ROIC) is -48.80%.

Return on Equity (ROE)	-86.73%
Return on Assets (ROA)	-8.08%
Return on Invested Capital (ROIC)	-48.80%
Return on Capital Employed (ROCE)	-51.17%
Weighted Average Cost of Capital (WACC)	11.86%
Revenue Per Employee	1.65B
Profits Per Employee	-236.63M
Employee Count	90
Asset Turnover	2.01
Inventory Turnover	18.03

Taxes

Income Tax	-241.73M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -22.89% in the last 52 weeks. The beta is 1.54, so Cellumed's price volatility has been higher than the market average.

Beta (5Y)	1.54
52-Week Price Change	-22.89%
50-Day Moving Average	1,271.34
200-Day Moving Average	950.94
Relative Strength Index (RSI)	46.66
Average Volume (20 Days)	8,604,487

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellumed had revenue of KRW 148.55 billion and -21.30 billion in losses. Loss per share was -400.81.

Revenue	148.55B
Gross Profit	6.22B
Operating Income	-9.54B
Pretax Income	-21.67B
Net Income	-21.30B
EBITDA	-8.75B
EBIT	-9.54B
Loss Per Share	-400.81

Balance Sheet

The company has 4.74 billion in cash and 12.13 billion in debt, with a net cash position of -7.39 billion or -134.58 per share.

Cash & Cash Equivalents	4.74B
Total Debt	12.13B
Net Cash	-7.39B
Net Cash Per Share	-134.58
Equity (Book Value)	16.52B
Book Value Per Share	296.79
Working Capital	2.51B

Cash Flow

In the last 12 months, operating cash flow was -4.13 billion and capital expenditures -529.05 million, giving a free cash flow of -4.66 billion.

Operating Cash Flow	-4.13B
Capital Expenditures	-529.05M
Free Cash Flow	-4.66B
FCF Per Share	-84.82

Margins

Gross margin is 4.18%, with operating and profit margins of -6.42% and -14.34%.

Gross Margin	4.18%
Operating Margin	-6.42%
Pretax Margin	-14.59%
Profit Margin	-14.34%
EBITDA Margin	-5.89%
EBIT Margin	-6.42%
FCF Margin	n/a

Dividends & Yields

Cellumed does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-13.80%
Shareholder Yield	-13.80%
Earnings Yield	-25.99%
FCF Yield	-5.69%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on April 28, 2017. It was a reverse split with a ratio of 0.1.

Last Split Date	Apr 28, 2017
Split Type	Reverse
Split Ratio	0.1

Scores

Cellumed has an Altman Z-Score of -0.12 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.12
Piotroski F-Score	2